---
input_text: Living donor liver transplantation for pediatric patients with inheritable
  metabolic disorders. Forty-six pediatric patients who underwent living donor liver
  transplantation (LDLT) using parental liver grafts for inheritable metabolic disorders
  (IMD) were evaluated to determine the outcomes of the surgery, decisive factors
  for post-transplant patient survival and the impact of using donors who were heterozygous
  for the particular disorder. Disorders included Wilson disease (WD, n = 21), ornithine
  transcarbamylase deficiency (OTCD, n = 6), tyrosinemia type I (TTI, n = 6), glycogen
  storage disease (GSD, n = 4), propionic acidemia (PPA, n = 3), methylmalonic acidemia
  (MMA, n = 2), Crigler-Najjar syndrome type I (CNSI, n = 2), bile acid synthetic
  defect (BASD, n = 1) and erythropoietic protoporphyria (EPP, n = 1). The post-transplant
  cumulative patient survival rates were 86.8 and 81.2% at 1 and 5 years, respectively.
  Post-transplant patient survival and recovery of the growth retardation were significantly
  better in the liver-oriented diseases (WD, OTCD, TTI, CNSI and BASD) than in the
  non-liver-oriented diseases (GSD, PPA, MMA and EPP) and pre-transplant growth retardation
  disadvantageously affected post-transplant outcomes. Although 40 of 46 donors were
  considered heterozygous for each disorder, neither mortality nor morbidity related
  to the heterozygosis has been observed. LDLT using parental donors can be recommended
  as an effective treatment for pediatric patients with IMD. In the non-liver-oriented
  diseases, however, satisfactory outcomes were not obtained by hepatic replacement
  alone.
raw_completion_output: |-
  primary_disease: inheritable metabolic disorders (IMD)

  medical_actions: living donor liver transplantation (LDLT);Using parental liver grafts;Evaluating patient survival;Assessing post-transplant outcomes;Treatment recommendation for pediatric patients

  symptoms: growth retardation

  chemicals: 

  action_annotation_relationships: living donor liver transplantation (LDLT) TREATS inheritable metabolic disorders (IMD) IN inheritable metabolic disorders;Using parental liver grafts TREATS inheritable metabolic disorders (IMD) IN inheritable metabolic disorders;Evaluating patient survival TREATS inheritable metabolic disorders (IMD) IN inheritable metabolic disorders;Assessing post-transplant outcomes TREATS growth retardation IN inheritable metabolic disorders;Treatment recommendation for pediatric patients TREATS inheritab le metabolic disorders (IMD) IN inheritable metabolic disorders
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  Treatment recommendation for pediatric patients TREATS inheritab le metabolic disorders (IMD) IN inheritable metabolic disorders

  ===

extracted_object:
  primary_disease: inheritable metabolic disorders (IMD)
  medical_actions:
    - living donor liver transplantation (LDLT)
    - Using parental liver grafts
    - Evaluating patient survival
    - Assessing post-transplant outcomes
    - Treatment recommendation for pediatric patients
  symptoms:
    - HP:0001510
  action_annotation_relationships:
    - subject: living donor liver transplantation
      predicate: TREATS
      object: inheritable metabolic disorders
      qualifier: inheritable metabolic disorders
    - subject: <Using parental liver grafts>
      predicate: <TREATS>
      object: <inheritable metabolic disorders (IMD)>
      qualifier: <inheritable metabolic disorders>
      subject_extension: <parental liver grafts>
    - subject: <Evaluating patient survival>
      predicate: <TREATS>
      object: <inheritable metabolic disorders (IMD)>
      qualifier: <inheritable metabolic disorders>
      subject_qualifier: <Not applicable>
      object_qualifier: <Not applicable>
      subject_extension: <Not applicable>
      object_extension: <Not applicable>
    - subject: Assessing post-transplant outcomes
      predicate: TREATS
      object: HP:0001510
      qualifier: inheritable metabolic disorders
    - subject: Treatment recommendation for pediatric patients
      predicate: TREATS
      object: inheritable metabolic disorders
      qualifier: inheritable metabolic disorders
named_entities:
  - id: MONDO:0010200
    label: Wilson disease
  - id: MAXO:0001175
    label: liver transplantation
  - id: MAXO:0000004
    label: surgery (laparotomy, rectal mobilization, rectopexy, the partial sigmoid
      colon resection with the primary anastomosis)
  - id: HP:0002910
    label: abnormal liver functions
  - id: HP:0001394
    label: cirrhosis
  - id: CHEBI:27363
    label: zinc
  - id: CHEBI:50868
    label: penicillamine
  - id: CHEBI:51232
    label: Hoechst 33342
  - id: HP:0006554
    label: acute liver failure
  - id: MAXO:0000068
    label: transplantation
  - id: MAXO:0009095
    label: Zinc therapy
  - id: HP:0002344
    label: Neurologic deterioration
  - id: MAXO:0001298
    label: therapy
  - id: HP:0001392
    label: liver disease
  - id: HP:0006579
    label: neonatal jaundice
  - id: HP:0002612
    label: congenital hepatic fibrosis
  - id: HP:0001409
    label: portal hypertension
  - id: HP:0030151
    label: cholangitis
  - id: MONDO:0013282
    label: alpha-1-antitrypsin deficiency
  - id: MONDO:0009061
    label: cystic fibrosis
  - id: MONDO:0009044
    label: Crigler-Najjar syndrome
  - id: MAXO:0000376
    label: liver biopsy
  - id: MAXO:0000127
    label: genetic testing
  - id: HP:0001903
    label: anemia
  - id: HP:0001410
    label: liver dysfunction
  - id: CHEBI:39501
    label: trientine
  - id: CHEBI:28694
    label: copper
  - id: HP:0001399
    label: hepatic failure
  - id: HP:0004448
    label: fulminant hepatic failure
  - id: CHEBI:35341
    label: Steroids
  - id: CHEBI:33281
    label: Antibiotics
  - id: MONDO:0100193
    label: end-stage liver disease
  - id: HP:0100626
    label: end-stage liver disease
  - id: HP:0100660
    label: dyskinesia
  - id: HP:0004787
    label: fulminant hepatitis
  - id: HP:0031811
    label: bilirubinuria
  - id: HP:0001397
    label: hepatic steatosis
  - id: CHEBI:16359
    label: cholic acid
  - id: MONDO:0019542
    label: Acute liver failure (ALF)
  - id: HP:0002480
    label: Hepatic encephalopathy
  - id: CHEBI:27385
    label: CCL4
  - id: MAXO:0001017
    label: Vaccination
  - id: HP:0001541
    label: Ascites
  - id: HP:0012398
    label: Peripheral edema
  - id: HP:0001337
    label: tremor
  - id: HP:0001260
    label: dysarthria
  - id: HP:0000708
    label: psychiatric disorders
  - id: HP:0200123
    label: chronic hepatitis
  - id: CHEBI:38161
    label: chelators
  - id: MAXO:0000603
    label: peritoneal dialysis
  - id: CHEBI:7959
    label: D-penicillamine
  - id: HP:0200032
    label: Kayser-Fleischer rings
  - id: HP:0002172
    label: imbalance
  - id: HP:0000093
    label: proteinuria
  - id: HP:0032199
    label: abnormal prothrombin time
  - id: MAXO:0000167
    label: Antiepileptic therapy
  - id: CHEBI:61049
    label: Tacrolimus
  - id: CHEBI:9168
    label: Rapamycin
  - id: CHEBI:55379
    label: Cyclosporine (CsA)
  - id: CHEBI:35623
    label: antiepileptic
  - id: CHEBI:4031
    label: Cyclosporine
  - id: HP:0000083
    label: renal failure
  - id: CHEBI:26708
    label: NA
  - id: CHEBI:35176
    label: zinc sulphate
  - id: HP:0001251
    label: ataxia
  - id: CHEBI:166831
    label: copper chelators
  - id: HP:0006577
    label: macronodular cirrhosis
  - id: CHEBI:8830
    label: rhodanine
  - id: CHEBI:18248
    label: iron
  - id: HP:0002015
    label: dysphagia
  - id: MONDO:0021200
    label: Rare diseases
  - id: MAXO:0000011
    label: Physiotherapy
  - id: MONDO:0001516
    label: spinal muscular atrophy
  - id: HP:0100806
    label: Sepsis
  - id: CHEBI:2948
    label: Azathioprine
  - id: CHEBI:8378
    label: Prednisolone
  - id: HP:0031690
    label: opportunistic infections
  - id: HP:0001513
    label: Obesity
  - id: HP:0000819
    label: Diabetes
  - id: HP:0002829
    label: Arthralgia
  - id: HP:0003281
    label: Elevated serum ferritin
  - id: HP:0012463
    label: Elevated transferrin saturation
  - id: CHEBI:9907
    label: Ursodeoxycholic acid
  - id: MONDO:0007027
    label: Non-alcoholic steatohepatitis (NASH)
  - id: MONDO:0006507
    label: Hereditary hemochromatosis (HH)
  - id: HP:0003256
    label: Coagulopathy
  - id: HP:0001298
    label: Encephalopathy
  - id: HP:0000952
    label: Jaundice
  - id: HP:0001289
    label: Confusion
  - id: MONDO:0003441
    label: dystonia
  - id: MAXO:0009015
    label: botulinum toxin injection
  - id: MAXO:0000943
    label: deep brain stimulation
  - id: CHEBI:9720
    label: trihexyphenidyl
  - id: HP:0001332
    label: dystonia
  - id: HP:0004305
    label: involuntary movements
  - id: CHEBI:46195
    label: acetaminophen
  - id: HP:0100520
    label: oliguria
  - id: CHEBI:16737
    label: creatinine
  - id: HP:0003259
    label: elevated creatinine
  - id: HP:0100543
    label: Cognitive impairment
  - id: CHEBI:33234
    label: vitamin E
  - id: MAXO:0000070
    label: Hepatic transplantation
  - id: HP:0001942
    label: metabolic acidosis
  - id: HP:0001953
    label: diabetic ketoacidosis (DKA)
  - id: CHEBI:145810
    label: insulin
  - id: HP:0003781
    label: Hypersalivation
  - id: HP:0002315
    label: Headache
  - id: HP:0002027
    label: Abdominal pain
  - id: HP:0002240
    label: Hepatomegaly
  - id: HP:0001744
    label: Splenomegaly
  - id: HP:0001873
    label: Thrombocytopenia
  - id: HP:0001250
    label: Convulsions
  - id: HP:0100785
    label: Insomnia
  - id: HP:0003394
    label: Muscle cramps
  - id: HP:0003401
    label: Paresthesia
  - id: HP:0025406
    label: Weakness
  - id: CHEBI:8764
    label: Mycophenolate mofetil
  - id: MONDO:0019737
    label: Thrombotic microangiopathy (TMA)
  - id: CHEBI:37153
    label: calcineurin inhibitors
  - id: MAXO:0001001
    label: gene therapy
  - id: CHEBI:30703
    label: tetrathiomolybdate
  - id: HP:0002878
    label: respiratory failure
  - id: HP:0001892
    label: hemorrhagic diathesis
  - id: HP:0011967
    label: copper deficiency
  - id: MAXO:0000647
    label: Chemotherapy
  - id: MONDO:0004952
    label: Hodgkin's disease
  - id: MAXO:0000533
    label: Molecular genetic testing
  - id: HP:0001878
    label: Haemolytic anaemia
  - id: CHEBI:62984
    label: Zinc acetate
  - id: HP:0001875
    label: neutropenia
  - id: MAXO:0001077
    label: splenectomy
  - id: HP:0005521
    label: local disseminated intravascular coagulation (DIC)
  - id: CHEBI:6888
    label: methylprednisolone
  - id: CHEBI:4027
    label: cyclophosphamide
  - id: CHEBI:15544
    label: prostaglandin E1
  - id: HP:0005912
    label: Biliary atresia
  - id: HP:0200084
    label: Neonatal hepatitis
  - id: HP:0004420
    label: Arterial thrombosis
  - id: HP:0031368
    label: Bowel perforation
  - id: MONDO:0100192
    label: liver failure
  - id: HP:0001510
    label: growth retardation
